BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8331739)

  • 1. Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.
    Hannibal MC; Markovitz DM; Clark N; Nabel GJ
    J Virol; 1993 Aug; 67(8):5035-40. PubMed ID: 8331739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
    Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
    Tong-Starksen SE; Welsh TM; Peterlin BM
    J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cis-acting elements in the human immunodeficiency virus type 2 enhancer mediate the response to T-cell receptor stimulation by antigen in a T-cell hybridoma line.
    Hannibal MC; Markovitz DM; Nabel GJ
    Blood; 1994 Apr; 83(7):1839-46. PubMed ID: 8142652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.
    Markovitz DM; Smith MJ; Hilfinger J; Hannibal MC; Petryniak B; Nabel GJ
    J Virol; 1992 Sep; 66(9):5479-84. PubMed ID: 1501284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.
    Leiden JM; Wang CY; Petryniak B; Markovitz DM; Nabel GJ; Thompson CB
    J Virol; 1992 Oct; 66(10):5890-7. PubMed ID: 1527846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW; Talmage DA; Viglianti GA
    J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.
    Sakaguchi M; Zenzie-Gregory B; Groopman JE; Smale ST; Kim SY
    J Virol; 1991 Oct; 65(10):5448-56. PubMed ID: 1895393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.
    Clark NM; Hannibal MC; Markovitz DM
    J Virol; 1995 Aug; 69(8):4854-62. PubMed ID: 7609053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes.
    Arenzana-Seisdedos F; Fernandez B; Dominguez I; JacquƩ JM; Thomas D; Diaz-Meco MT; Moscat J; Virelizier JL
    J Virol; 1993 Nov; 67(11):6596-604. PubMed ID: 8411362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Twu JS; Chu K; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
    Tsang SX; Morris GF; Lu M; Morris CB
    Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
    Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K
    J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.
    Niederman TM; Garcia JV; Hastings WR; Luria S; Ratner L
    J Virol; 1992 Oct; 66(10):6213-9. PubMed ID: 1527859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.